Literature DB >> 22137681

Nontuberculous mycobacterial infections in cancer patients in a medical center in Taiwan, 2005-2008.

Chih-Cheng Lai1, Che-Kim Tan, Aristine Cheng, Kuei-Pin Chung, Chien-Yuan Chen, Chun-Hsing Liao, Yu-Tsung Huang, Po-Ren Hsueh.   

Abstract

Data on the nontuberculous mycobacterial (NTM) species that cause infection and the characteristics of disease caused by these pathogens in cancer patients are limited, so we perform this study to investigate the species distribution of NTM isolates from various clinical specimens and to elucidate the epidemiologic trends in NTM isolates and diseases among cancer patients. From 2005 through 2008, cancer patients with NTM infections as defined by the American Thoracic Society/Infectious Diseases Society of America criteria were identified at the National Taiwan University Hospital. The medical records of all patients were reviewed. During the study period, a total of 219 cancer patients with NTM infections were identified. Among them, 133 (60.7%) patients were older than 65 years, most of whom were men. Lung cancer was the most common type of cancer, followed by hematologic cancer and gastrointestinal tract cancer. Pulmonary NTM infection was the most common type of infection in 205 (93.6%) patients, followed by skin and soft tissue infections (n = 7, 3.2%), disseminated infections (n = 4, 1.8%), and genitourinary tract infection (n = 3, 1.4%). Disseminated infections occurred exclusively in patients with hematologic cancer. Mycobacterium avium complex (MAC) caused the majority of pulmonary NTM infections in cancer patients; in contrast, M. abscessus was the most common causative pathogen of extrapulmonary NTM diseases, followed by MAC. In conclusion, physicians need to be aware of the possibility of co-existing pulmonary NTM infection in patients with lung cancer. In addition, disseminated NTM infection should be considered in patients with hematologic cancer.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22137681     DOI: 10.1016/j.diagmicrobio.2011.10.006

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  6 in total

1.  The impact of cancer development on the risk of mycobacterial diseases among rheumatoid arthritis patients.

Authors:  S-W Pan; Y-F Yen; Y R Kou; P-H Chuang; J-Y Feng; Y-J Chan; W-J Su
Journal:  Epidemiol Infect       Date:  2017-07-24       Impact factor: 4.434

2.  Nontuberculosis mycobacterial infections at a specialized tuberculosis treatment centre in the Republic of Korea.

Authors:  Hee Jung Yoon; Hwa Young Choi; Moran Ki
Journal:  BMC Infect Dis       Date:  2017-06-15       Impact factor: 3.090

3.  Characteristics of Mycobacterium avium complex (MAC) pulmonary disease in previously treated lung cancer patients.

Authors:  Erin Meier; Kelly Pennington; Alice Gallo de Moraes; Patricio Escalante
Journal:  Respir Med Case Rep       Date:  2017-06-23

Review 4.  Pulmonary non-tuberculous mycobacterial infections: current state and future management.

Authors:  Kai Ling Chin; Maria E Sarmiento; Nadine Alvarez-Cabrera; Mohd Nor Norazmi; Armando Acosta
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-12-18       Impact factor: 3.267

5.  Incidence, comorbidities, and treatment patterns of nontuberculous mycobacterial infection in South Korea.

Authors:  Hye Ok Kim; Kyungjong Lee; Hee Kyoung Choi; Sangmi Ha; Sang Moo Lee; Gi Hyeon Seo
Journal:  Medicine (Baltimore)       Date:  2019-11       Impact factor: 1.817

6.  MAC Attack: Clinical Correlates of Mycobacterium avium Complex Infection Among Patients With and Without Cancer.

Authors:  Karan Gupta; Marc B Feinstein; Debra A Goldman; Hassan S Patail; Diane E Stover
Journal:  J Clin Med Res       Date:  2020-03-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.